Piper Sandler Reiterates Overweight Rating on Moderna (MRNA)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 203.21 +13.20 (6.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $190.01 | 52 Week High | $0.52 | |||
| Open | $191.41 | 52 Week Low | $0.08 | |||
| Day High | $205.77 | P/E | N/A | |||
| Day Low | $185.90 | EPS | $-3.80 | |||
| Volume | 19,307,573 | |||||
